Literature DB >> 29128260

Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology.

Aleix Cases1, M Isabel Egocheaga2, Salvador Tranche3, Vicente Pallarés4, Raquel Ojeda1, José Luis Górriz5, José María Portolés1.   

Abstract

The objective of this protocol is to know which test are needed to study an anaemia in a patient with chronic kidney disease, the differential diagnosis of renal anaemia, to know and correct other deficiency anaemias, and the criteria for referral to Nephrology or other specialties of the anaemic patient with chronic kidney disease.
Copyright © 2017 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Agentes estimuladores de la eritropoyesis; Anaemia; Anemia; Atención Primaria; Chronic kidney disease; Enfermedad renal crónica; Erythropoiesis stimulating agents; Ferroterapia; Iron therapy; Primary care

Mesh：

Substances：

Year:  2017        PMID： 29128260     DOI： 10.1016/j.nefro.2017.09.004

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN： 2013-2514


  13 in total

Review 1.  Risk Factors for Anemia in Patients with Chronic Renal Failure: A Systematic Review and Meta-Analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Yared Asmare Aynalem
Journal:  Ethiop J Health Sci       Date:  2020-09

2.  Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice.

Authors:  Sutada Lotinun; Korakot Atjanasuppat; Jutatip Limsuvech; Asada Leelahavanichkul; Saovaros Svasti; Nateetip Krishnamra
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

3.  Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort.

Authors:  Emily de Souza Ferreira; Tiago Ricardo Moreira; Rodrigo Gomes da Silva; Glauce Dias da Costa; Luciana Saraiva da Silva; Samantha Bicalho de Oliveira Cavalier; Beatriz Oliveira Silva; Heloísa Helena Dias; Luiza Delazari Borges; Juliana Costa Machado; Rosângela Minardi Mitre Cotta
Journal:  BMC Nephrol       Date:  2020-11-23       Impact factor: 2.388

4.  The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients.

Authors:  Hanan AlKharboush; Fatimah Alshehri; Ibrahim Alatwi; Khaled Al Karni; Abdurahman Alatawi; Ahmed M Hamdan
Journal:  Cureus       Date:  2020-12-04

5.  Prevalence of Anemia and Its Associated Factors Among Chronic Kidney Disease Patients Attending Selected Public Hospitals of Addis Ababa, Ethiopia: Institutional-Based Cross-Sectional Study.

Authors:  Birhie Alemu; Tesfaye Techane; Negalign Getahun Dinegde; Yosief Tsige
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-03-05

6.  Acoustic Characteristics of Voice in Patients with Chronic Kidney Disease.

Authors:  Fatma Mohammed Abd El-Gaber; Yossra Sallam; Hanaa Mohammed Eid El Sayed
Journal:  Int J Gen Med       Date:  2021-06-11

7.  Erythrogram Patterns in Dogs with Chronic Kidney Disease.

Authors:  Ilaria Lippi; Francesca Perondi; George Lubas; Eleonora Gori; Alessio Pierini; Alessandra D'Addetta; Veronica Marchetti
Journal:  Vet Sci       Date:  2021-06-30

Review 8.  The Influence of Inflammation on Anemia in CKD Patients.

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Robert Olszewski; Jacek Rysz
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

9.  Decreased Preoperative Estimated Glomerular Filtration Rate Was Related With Poor Prognosis of NSCLC Patients.

Authors:  Wenqiao Jia; Cong Wang; Yufeng Cheng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Design and methodology of the chronic kidney disease as a dysmetabolic determinant of disability among older people (CKD-3D) study: a multicenter cohort observational study.

Authors:  Andrea Corsonello; Francesco Mattace-Raso; Lisanne Tap; Marcello Maggio; Luna Zerbinati; Francesco Guarasci; Annalisa Cozza; Sonia D'Alia; Luca Soraci; Valentina Corigliano; Mirko Di Rosa; Paolo Fabbietti; Fabrizia Lattanzio
Journal:  Aging Clin Exp Res       Date:  2021-01-03       Impact factor: 3.636
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.